After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Verona Pharma Plc ADR is $6.60B. A total of 1.46 million shares were traded on the day, compared to an average of 1.36M shares.
In the most recent transaction, Hahn Mark W sold 204,864 shares of VRNA for 9.33 per share on May 29 ’25. After the transaction, the Chief Financial Officer now owns 12,678,992 company shares. In a previous transaction on May 28 ’25, Hahn Mark W sold 162,704 shares at 9.30 per share. VRNA shares that Chief Financial Officer owns now total 12,883,856.
Among the insiders who sold shares, Hahn Mark W disposed of 32,432 shares on May 27 ’25 at a per-share price of $9.53. This resulted in the Chief Financial Officer holding 13,046,560 shares of VRNA after the transaction. In another insider transaction, ZACCARDELLI DAVID sold 208,696 shares at $9.33 per share on May 29 ’25. Company shares held by the President and CEO now total 13,590,168.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, VRNA has a high of $76.92 and a low of $11.39.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. VRNA’s latest balance sheet shows that the firm has $148.38M in Cash & Short Term Investments as of fiscal 2021. There were $5.81M in debt and $33.42M in liabilities at the time. Its Book Value Per Share was $2.66, while its Total Shareholder’s Equity was $148.00M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRNA is Buy with a score of 5.00.
